Although certain members of the sulfonamide group of drugs have been used in the treatment of the complications of whooping cough, 4' 5' 7, 8, 9, 12, 13 but little attention has been given to their effect on the specific organism, Hemophilus pertwssis. Previous work" ' has failed to show a favorable influence of sulfanilamide and sulfapyridine on the course of experimental pertussis in the mouse. A recent report by Hornibrook' indicates that sulfadiazine is definitely effective on the course of experimental infection produced by H. pertussis in the rat. Hornibrook's report and our own studies on immune rabbit serums led us to investigate the effect of sulfadiazine alone and in combination with serum in experimental pertussis.
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Method and materials Three-week-old Swiss mice, of uniform size, were infected while under light ether anesthesia by dropping varying dilutions of a standardized suspension of H. pertussis into the nares. The suspension of organisms was prepared by washing the 72-hour growth of H. pertussis from the surface of Bordet's medium into 0.85 per cent sodium chloride solution. It was diluted to contain approximately 10 billion organisms per milliliter. The mice were separated into 5 subgroups of 6 mice each, and the infecting doses for the subgroups were 250, 62.5, 15.6, 3.9, and 0.97 million organisms, respectively.
Since these experiments were designed to test the therapeutic effect, administration of the drug and of the serums was made 24 hours after the inoculation of the mice. The sulfadiazine in 0.5 per cent solution was injected intra-abdominally twice daily in amounts such that the total daily dose was 0.1 gm. per kg. of body weight. The injections were continued for 7 days.
Two dilution, injected intra-abdominally 24 hours after infection of the mouse. Daily injections were continued for a period of 7 days. The mice were observed for 10 days, during which period the mortality rate of each group was determined. Surviving mice were killed at the end of the 10-day period, at which time cultures were made from the lungs. The criteria employed to measure the therapeutic effectiveness of the agents tested were: (a) mortality rate; (b) the clearance of the organisms from the lungs of the surviving mice. By using the fifty per cent end-point method described by Reed Since it is known that an antibacterial serum11 is definitely protective in experimental murine pertussis, it was decided to test the effect of sulfadiazine in combination with these biological products and to compare the results with those obtained by treatment with either the drug alone or with serum alone. The results of two such experiments are presented in Table 2 .
From the data of the first experiment (Table 2) it is evident that the number of organisms (111 million) necessary to kill fifty per cent of the mice treated with sulfadiazine was almost 22 times that (5 million) required to kill the controls. The M.L.D. for the mice treated 24 hours after infection with immune rabbit globulin was 109 million organisms, while that of the group receiving combined drug and serum treatment was 62 million organisms. In this experiment, therefore, the protective power of either the drug alone, or of the serum alone was greater than that of the conmbination of the two agents. In the second experiment, the combined therapy gave a slightly better result than did serum alone and a definitely better result than did sulfadiazine alone.
In the effect on the disappearance of the organisms from the lungs of surviving mice the difference between the serum-treated or the drug-treated and the combined serum-and drug-treated group was distinctly in favor of the combined therapy. In experiment 1 ( Table  2 ) 56 per cent of the sulfadiazine-treated group and 55 per cent of the serum-treated group yielded positive cultures, while only 8 per cent of the combined-treated group were positive. This difference in favor of combined therapy is statistically significant in both experiments 1 and 2. This clearing effect was even more marked than is apparent from the protocols, because the relative number of colonies is not shown. In many instances, only a few colonies (sometimes only a single one) were observed on cultures of the lungs of the mice receiving the combined type of treatment. These mice, of course, were tabulated in the protocols as having positive cultures.
The data given in Table 3 (experiment 1) show that a combination of sulfadiazine and pertussis antitoxin was not only more protective than either drug or antitoxin alone, but also that only the combined therapy was effective in causing the disappearance of the organisms from the lungs of surviving mice. In experiment 2 this was also true, but less significant, because both the drug and the antitoxin alone were equally as effective.
In general, the data included in Table 2 show that sulfadiazine and the immune globulin alone were each effective once, but failed once, to produce clearing of the organisms from the lungs, while in combination they were effective in both experiments. A similar conclusion may be drawn from the data of Table 3 concerning sulfadiazine and the antitoxin.
The practical application of the combined therapy to the treatment of early cases of pertussis in infants is obvious. The difficulty encountered in accurately assessing the therapeutic value of any agent in whooping cough is equally obvious. One of the criteria which can be controlled, however, is the dearing of the organisms from the naso-pharynx as tested by repeated nasopharyngeal cultures. 2 The results of such a study, now in progress in our clinic, indicate that a rapid disappearance of H. pertussis from the upper respiratory tract occurs when sulfadiazine and the antibacterial serum (immune globulin) are administered to infants during the catarrhal period of the disease. Sumnary Sulfadiazine, an immune rabbit globulin (anti-bacterial serum), and an antitoxin were each found to protect mice against experimental murine pertussis when administered 24 hours after infection. Each of these therapeutic agents brought about the disappearance of the organisms from the lungs of surviving mice, but this effect was not always reproducible.
When a combined form of therapy, consisting in either sulfadiazine with immune rabbit globulin or sulfadiazine with antitoxin, was used there was effective clearance of the organisms from the lungs and protection of the mice from death.
